CAPLIPOINT

Caplin Point Laboratories Share Price

₹1,933.25 -18.9 (-0.97%)

21 Nov, 2024 14:31

SIP TrendupStart SIP in CAPLIPOINT

Start SIP

Performance

  • Low
  • ₹1,923
  • High
  • ₹1,974
  • 52 Week Low
  • ₹1,178
  • 52 Week High
  • ₹2,177
  • Open Price₹1,950
  • Previous Close₹1,952
  • Volume54,806

Investment Returns

  • Over 1 Month + 0.33%
  • Over 3 Month + 8.73%
  • Over 6 Month + 47.02%
  • Over 1 Year + 52.27%
SIP Lightning

Smart Investing Starts Here Start SIP with Caplin Point Laboratories for Steady Growth!

Invest Now

Caplin Point Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.8
  • PEG Ratio
  • 1.6
  • Market Cap Cr
  • 14,695
  • P/B Ratio
  • 6.5
  • Average True Range
  • 80.8
  • EPS
  • 64.93
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 25.16
  • RSI
  • 49.14
  • MFI
  • 68.82

Caplin Point Laboratories Financials

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹1,933.25
-18.9 (-0.97%)
pointer
  • stock-down_img
  • Bullish Moving Average 6
  • stock-up_img
  • Bearish Moving Average 10
  • 20 Day
  • ₹1,971.20
  • 50 Day
  • ₹1,917.19
  • 100 Day
  • ₹1,803.14
  • 200 Day
  • ₹1,623.00

Resistance and Support

1965.33 Pivot Speed
  • R3 2,046.12
  • R2 2,023.58
  • R1 1,987.87
  • S1 1,929.62
  • S2 1,907.08
  • S3 1,871.37

What's your outlook on Caplin Point Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Caplin Point Laboratories is a rapidly growing pharmaceutical company with a strong presence in Latin America, Francophone Africa, and expanding into regulated markets like the USA and EU. it specializes in manufacturing and distributing a wide range of pharmaceutical products.

Caplin Point Labs. has an operating revenue of Rs. 1,830.78 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 33% is great, ROE of 20% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 23% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -9% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Caplin Point Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-07 Quarterly Results
2024-08-07 Quarterly Results & Final Dividend
2024-05-16 Audited Results & Interim Dividend
2024-02-09 Quarterly Results
2023-11-09 Quarterly Results
Date Purpose Remarks
2024-05-31 INTERIM Rs.2.50 per share(125%)Interim Dividend
2023-06-09 INTERIM Rs.2.00 per share(100%)Interim Dividend
2022-05-24 INTERIM Rs.2.00 per share(100%)Interim Dividend
2021-05-19 INTERIM Rs.1.50 per share(75%)Interim Dividend

Caplin Point Laboratories F&O

Caplin Point Laboratories Shareholding Pattern

70.56%
1.62%
0.15%
3.71%
0%
17.12%
6.84%

About Caplin Point Laboratories

  • NSE Symbol
  • CAPLIPOINT
  • BSE Symbol
  • 524742
  • Managing Director
  • Dr. Sridhar Ganesan
  • ISIN
  • INE475E01026

Similar Stocks to Caplin Point Laboratories

Caplin Point Laboratories FAQs

Caplin Point Laboratories share price is ₹1,933 As on 21 November, 2024 | 14:17

The Market Cap of Caplin Point Laboratories is ₹14695 Cr As on 21 November, 2024 | 14:17

The P/E ratio of Caplin Point Laboratories is 29.8 As on 21 November, 2024 | 14:17

The PB ratio of Caplin Point Laboratories is 6.5 As on 21 November, 2024 | 14:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23